8251 - 8300 of 8824 Results
Title
Year
-
RESTRICTEDTitle: Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 654End Page: 654Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28936Citation Count: 2
-
OPENTitle: The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of LifeJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 291End Page: 301Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28952Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28952Citation Count: 22
- Lateralized Subthalamic Stimulation for Axial Dysfunction in Parkinson's Disease: A Randomized Trial2022RESTRICTEDTitle: Lateralized Subthalamic Stimulation for Axial Dysfunction in Parkinson's Disease: A Randomized TrialJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1079End Page: 1087Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28953Citation Count: 16
-
RESTRICTEDTitle: The Neuroinflammatory Acute Phase Response in Parkinsonian‐Related DisordersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 993End Page: 1003Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28958Citation Count: 14
-
RESTRICTEDTitle: Physician‐Assisted Dying: Access and Utilization in Patients with Movement DisordersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 694End Page: 698Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28964Citation Count: 4
- The Role of Insular Cortex in Gut‐Inflammation Memory: What Does It Mean for Parkinson's Disease?2022RESTRICTEDTitle: The Role of Insular Cortex in Gut‐Inflammation Memory: What Does It Mean for Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 700End Page: 701Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28975Citation Count: 2
-
RESTRICTEDTitle: Implementation and Outcomes of a Movement Disorder Society‐Sponsored Peer Reviewing Education and Mentoring ProgramJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1093End Page: 1097Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28978Citation Count: 3
- Abstracts2022RESTRICTEDTitle: AbstractsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: S1Start Page: S1End Page: S36Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29002Citation Count: 0
- Exposure to Pesticides Predicts Prodromal Feature of Parkinson's Disease: Public Health Implications2022OPENTitle: Exposure to Pesticides Predicts Prodromal Feature of Parkinson's Disease: Public Health ImplicationsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 883End Page: 885Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29012Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29012Citation Count: 6
-
OPENTitle: Parkin Deficiency Impairs Mitochondrial DNA Dynamics and Propagates InflammationJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1405End Page: 1415Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29025Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29025Citation Count: 73
-
RESTRICTEDTitle: Assessment of GGC Repeat Expansion in GIPC1 in Patients with Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1557End Page: 1559Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29041Citation Count: 14
-
RESTRICTEDTitle: TDP‐43 Proteinopathy Presenting with Typical Symptoms of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1561End Page: 1563Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29048Citation Count: 30
-
RESTRICTEDTitle: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1346End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29058Citation Count: 19
-
RESTRICTEDTitle: An MDS Evidence‐Based Review on Treatments for Huntington's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1566End Page: 1567Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29059Citation Count: 1
-
RESTRICTEDTitle: Reply to: “Diabetes and Neuroaxonal Damage in Parkinson's Disease”Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1569End Page: 1570Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29064Citation Count: 0
-
RESTRICTEDTitle: Corticobasal Syndrome with TAR Binding Protein 43–Positive Oligodendrocyte InclusionsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1564End Page: 1565Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29070Citation Count: 0
-
RESTRICTEDTitle: Mutation Screening of TFG in α‐Synucleinopathy and Amyotrophic Lateral SclerosisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1756End Page: 1761Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29079Citation Count: 5
-
OPENTitle: Coherent Structural and Functional Network Changes after Thalamic Lesions in Essential TremorJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 9Start Page: 1924End Page: 1929Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29130Citation Count: 15
-
RESTRICTEDTitle: Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1779End Page: 1781Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29132Citation Count: 15
-
RESTRICTEDTitle: Reply to: “Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations”?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1782End Page: 1782Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29136Citation Count: 0
- Editor's Note2022RESTRICTEDTitle: Editor's NoteJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1329End Page: 1329Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29149Citation Count: 0
-
RESTRICTEDTitle: Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric SignsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2888End Page: 2900Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28722Citation Count: 75
-
RESTRICTEDTitle: Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2208End Page: 2209Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28725Citation Count: 0
-
OPENTitle: Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related DisordersJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2874End Page: 2887Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28738Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28738Citation Count: 113
- Reply to: “α‐Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism”2021RESTRICTEDTitle: Reply to: “α‐Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2212End Page: 2213Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28742Citation Count: 1
-
OPENTitle: Polyglutamine‐Expanded Ataxin‐3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2675End Page: 2681Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28749Best OA location URL: https://doi.org/10.1002/mds.28749Citation Count: 35
-
RESTRICTEDTitle: Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohortJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 1Start Page: 226End Page: 243Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.12632Citation Count: 30
-
OPENTitle: Description of a European memory clinic cohort undergoing amyloid‐PET: The AMYPAD Diagnostic and Patient Management StudyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 844End Page: 856Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12696Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2022-01312%22Citation Count: 17
-
OPENTitle: Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivityJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 3Start Page: 956End Page: 966Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12697Best OA location URL: https://doi.org/10.1002/alz.12697Citation Count: 60
-
OPENTitle: Relationship of serum beta‐synuclein with blood biomarkers and brain atrophyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 4Start Page: 1358End Page: 1371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12790Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12790Citation Count: 50
-
OPENTitle: Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseasesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 6Start Page: 2618End Page: 2632Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12880Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11633037Citation Count: 26
-
OPENTitle: 146th Annual Meeting American Neurological AssociationJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: S27Start Page: S1End Page: S270Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26180Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26180Citation Count: 16
-
RESTRICTEDTitle: Neural Correlates of Optimal Deep Brain Stimulation for Cervical DystoniaJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 3Start Page: 418End Page: 424Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.26450Citation Count: 19
-
RESTRICTEDTitle: 147th Annual Meeting American Neurological AssociationJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: S29Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.26484Citation Count: 25
-
OPENTitle: Protective Effects of Lovastatin in a Population‐BasedALSStudy and Mouse ModelJournal Name: Annals of NeurologyPublisher: WileyVol: 93Issue #: 5Start Page: 881End Page: 892Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26600Citation Count: 11
-
OPENTitle: A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 MutationJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 2Start Page: 508End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.2277Citation Count: 18
-
OPENTitle: Multishank Thin‐Film Neural Probes and Implantation System for High‐Resolution Neural Recording ApplicationsJournal Name: Advanced Electronic MaterialsPublisher: WileyVol: 9Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/aelm.202200883Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/aelm.202200883Citation Count: 21
-
RESTRICTEDTitle: Soluble P‐tau217 reflects both amyloid and tau pathology in the human brain and mediates the association of amyloid with neocortical tauJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.050391Citation Count: 2
-
RESTRICTEDTitle: Machine learning‐based prediction of cognitive outcomes in de novo Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: S5Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.067067Citation Count: 6
-
RESTRICTEDTitle: Organizations join forces to support early diagnosis of Lewy body dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 6Start Page: 1077End Page: 1078Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.12386Citation Count: 0
-
RESTRICTEDTitle: Effect of Urate-Elevating Inosine on Progression of Early Parkinson DiseaseJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.21008Citation Count: 5
-
RESTRICTEDTitle: Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—ReplyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.21011Citation Count: 4
-
OPENTitle: Machine Learning for Predicting Rare Clinical Outcomes—Finding Needles in a HaystackJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 5Start Page: e2110738End Page: e2110738Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.10738Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2780278/wang_2021_ic_210094_1620949822.15523.pdfCitation Count: 21
- Reforming the Process for Deep Brain Stimulation and Neurologic Device Approval in Rare Diseases2020RESTRICTEDTitle: Reforming the Process for Deep Brain Stimulation and Neurologic Device Approval in Rare DiseasesJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 1Start Page: 5End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4232Citation Count: 3
-
RESTRICTEDTitle: Ischemic Events After Intracerebral HemorrhageJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 7Start Page: 795End Page: 795Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.0772Citation Count: 3
-
RESTRICTEDTitle: Bad Air and Parkinson Disease—The Fog May Be LiftingJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 7Start Page: 793End Page: 793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.0863Citation Count: 7
- Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson Disease2021OPENTitle: Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 12Start Page: 1443End Page: 1443Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.3744Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2785852/jamaneurology_de_vries_2021_ed_210020_1638811688.29228.pdfCitation Count: 15
-
RESTRICTEDTitle: Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?Journal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 119End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4140Citation Count: 5
-
RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601Citation Count: 0
-
RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—ReplyJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604Citation Count: 0